Developing a Successful Biopharmaceutical Pricing & Market Access Strategy
This course will provide academic researchers working in drug discovery and development with a deep understanding of biopharmaceutical pricing and market access, while outlining the key early considerations which need to be made to allow the right treatment to get to the right patient, at the right time and at the right price. Understanding how basic and early translational research outcomes can impact industry go / no-go and commercial strategy decisions will allow a more holistic view of the challenges and potentials in the development of novel biopharmaceuticals.
Join us for a 7 week virtual course to develop the knowledge and skills required to deliver a successful Life Science commercial strategy and become an industry leader.
7 Virtual Sessions, Once Weekly, 20 April – 8 June 2023; Virtual course, 1pm – 3.30pm Thursdays UK time (BST)
Registration: Please register for the course here
For full details on the course and speakers, please click here
Course Overview
This executive education programme is a collaboration between the Cambridge Academy of Therapeutic Sciences (CATS) and Windrose Consulting Group; experts in value and commercialisation strategies for the Life Sciences industry.
The course is a blend of lectures, case studies and practical exercises. We believe in an interactive approach, encouraging group discussion and exploring real-world situations. The aim is not just to provide the theory, but help you understand how to apply it within your role or future career.
What Will You Learn?
You will gain an in-depth understanding of how to achieve commercialisation excellence:
Develop and implement a successful Pricing & Market Access strategy
Understand how to pre-empt and address commercialisation challenges
Effectively communicate the value of a drug
Create strategies to adapt to a rapidly changing Life Science landscape
The theory and application of commercialisation strategy; with real life case studies, course work & feedback
Who Should Attend?
This course is aimed at present and future Life Science leaders.
Typical participants are:
Those interested in learning about or a career in the Life Sciences industry
Experienced professionals who wish to gain a strong understanding of commercialisation strategy
Those who are entering or transitioning into the commercial side of Life Sciences
Pricing & market access professionals seeking career advancement
Course Content
Module 1 - Pricing & Market Access (P&MA) Fundamentals: Thursday 20th April 2023 13:00 - 15:30 BST
An introductory overview of the role of P&MA and value-based pricing, which forms the foundation of any successful commercial strategy.
Module 2 - Measuring value through Health Economics: Thursday 27th April 2023 13:00 - 15:30 BST
Quantifying value through health economics and planning for successful health-technology appraisals
Module 3 - Stakeholders & Market Systems: Thursday 4th May 2023 13:00 - 15:30 BST
Understanding how stakeholders assess value and the decision making process for pricing and access.
Module 4 - Optimising the P&MA Strategy Part I: Thursday 11th May 2023 13:00 - 15:30 BST
Balancing the multitude of practical considerations when developing a P&MA strategy.
Module 5 - Optimising the P&MA Strategy Part II: Thursday 25th May 2023 13:00 - 15:30 BST
Balancing the multitude of practical considerations when developing a P&MA strategy
Module 6 - Stakeholder Engagement: Thursday 1st June 2023 13:00 - 15:30 BST
Engaging with stakeholders to ensure clear value comprehension to drive successful strategy implementation
Module 7 - Payer Engagement and P&MA Planning: Thursday 8th June 2023 13:00 - 15:30 BST
Tools and techniques for negotiation and implementing P&MA strategy throughout the lifecycle
Course Costs
Professional:
- Full course £2,500
Academics and Students:
- Full course £1,800
What this includes?
This includes course materials (digital copies) and tuition.
Group discounts may be available on request.
Registration: Please register for the course here
For more information, please contact:
Georgina Powell, Senior Analyst, Windrose Consulting Group (georgina.powell@windrosecg.com)
Jenny Versnel PhD, Cambridge Academy of Therapeutic Sciences (CATS) (jenny.versnel@admin.cam.ac.uk)
